Tower Research Capital LLC (Trc) Fusion Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.9 - $21.32 $19,750 - $53,300	-2,500 Reduced 83.11%	508 $10,000
Q4 2023 Feb 13, 2024	BUY	$2.48 - $9.65 $7,115 - $27,685	2,869 Added 2064.03%	3,008 $28,000
Q3 2023 Nov 14, 2023	BUY	$2.37 - $4.63 $329 - $643	139 New	139 $0
Q2 2022 Aug 15, 2022	BUY	$2.49 - $7.86 $8,114 - $25,615	3,259 New	3,259 $8,000
Q1 2022 May 12, 2022	SELL	$4.53 - $8.57 $5,254 - $9,941	-1,160 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.78 $6,229 - $11,623	-1,494 Reduced 56.29%	1,160 $5,000
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $2,826 - $3,397	-361 Reduced 11.97%	2,654 $21,000
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $11,612 - $15,531	1,457 Added 93.52%	3,015 $24,000
Q1 2021 May 17, 2021	BUY	$9.75 - $13.09 $15,190 - $20,394	1,558 New	1,558 $17,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.